Results 61 to 70 of about 8,229 (214)
Serum HE4 and CA125 combined to predict and monitor recurrence of type II endometrial carcinoma
There is no recognized serum biomarker to predict the recurrence of endometrial carcinoma (EC). We aimed to explore serum human epididymis protein 4 (HE4) and cancer antigen 125 (CA125) as the biomarkers to predict and monitor recurrence of type II EC ...
Quan Quan +5 more
doaj +1 more source
Through integrated proteomic and metabolomic profiling, Zhao et al. identified three molecular subtypes of high‐grade serous ovarian cancer. The high‐risk subtype exhibits activated arachidonic acid metabolism and cyclooxygenase‐2 overexpression. This metabolic axis promotes M2‐like macrophage infiltration, which contributes to platinum resistance ...
Yuxi Zhao +11 more
wiley +1 more source
Urinary concentrations of human epidydimis secretory protein 4 (He4) in the diagnosis of ovarian cancer : A case-control study [PDF]
Objective: To analyze differential diagnostic accuracy of urinary human epidydimis secretory protein 4 (HE4)in patients with ovarian tumors. Materials and methods: In the case-control study 23 patients with ovarian cancer, 37 patients with benign ovarian
Baidekalna, Ieva +2 more
core +1 more source
. Background:. Human epididymis secretory protein 4 (HE4) is a new ovarian cancer biomarker. The factors influencing HE4 levels are not clear, and the reference data in China are limited.
Hong-Yan Cheng +11 more
doaj +1 more source
ABSTRACT Although rare, ruptured mature cystic teratoma (MCT) can cause chronic granulomatous peritonitis that mimics peritoneal carcinomatosis. In patients with a history of cystectomy for MCT, careful clinicoradiologic and histopathologic correlation is essential to avoid misdiagnosis and unnecessary aggressive treatment.
Zohre Sadeghian +6 more
wiley +1 more source
ABSTRACT In a patient with advanced ovarian cancer showing limited response to paclitaxel–carboplatin, adding sintilimab was associated with R0 cytoreduction and sustained disease‐free status during olaparib–bevacizumab maintenance. This case provides a rationale for further investigation of PD‐1 blockade as neoadjuvant therapy in carefully selected ...
Wang Zhenyan, Wang Yan
wiley +1 more source
The Human Biomarker Navigator integrates the disease continuum, biomarker dynamics, cross‐organ biomarker networks, biomarker classification, and technology‐driven paradigms. It maps how biomarkers link multi‐system physiology and pathology across the nervous, respiratory, endocrine, circulatory, immune, digestive, urinary, reproductive, and ...
Meng‐Yao Li +29 more
wiley +1 more source
Comprehensive evaluation of serum HE4 and CA125 with HE4 immunohistochemistry for ovarian tumor diagnosis [PDF]
Ovarian tumors present a critical health challenge due to high mortality. Current diagnostic modality like Cancer antigen 125 (CA125) in terms of low sensitivity or ultrasound in terms of cost and expertise have its own limitations.
Atique, Amad S. +6 more
core +1 more source
Objective To analyze the change of serum human epididymis protein 4 concentrations in chronic kidney disease and the relationship between serum HE4 and renal fibrosis.Methods In190 female patients at different stages of chronic kidney disease(CKD) with ...
YANG Ping-zhen, HAN Hong-ling
doaj
Background/Aims: Human epididymal secretory protein 4 (HE4) is originally described as an epididymis-specific protein but more recently suggested to be a putative serum tumor marker for some tumors, including breast carcinomas. In this study, we aimed to
Gamze Akoz +4 more
doaj +1 more source

